Zacks Investment Research on MSN
J&J Up Around 17% in 3 Months: Should You Buy, Sell or Hold the Stock?
Johnson & Johnson’s JNJ stock has risen 16.7% in the past three months. A lot of this price increase is due to strong ...
The company recently announced the acquisition of a biotech with an innovative cancer treatment. Johnson & Johnson had strong ...
TipRanks on MSN
M&A News: Johnson & Johnson Stock (JNJ) Perks Up as it Lands $3B “Hold and Kill” Cancer Deal
Shares in medtech giant Johnson & Johnson ($JNJ) rose today as it said it would revolutionize cancer treatment following its ...
Johnson & Johnson (JNJ) shares have edged higher over the past month, building on a steady run that has seen the stock ...
Last month, Johnson & Johnson surged following a well-received quarterly earnings release. Despite a sluggish start to ...
After years of post-COVID-19 normalization and the impact of its Kenvue spinoff, Johnson & Johnson’s (NYSE: JNJ) stock price is back in rally mode. It is still early in the game, but the Q2 results ...
Johnson & Johnson stock rises on strong earnings, the Halda deal, FDA wins and an upcoming orthopedics spinoff as analysts weigh the outlook.
Johnson & Johnson (NYSE:JNJ – Free Report) had its target price lifted by Bank of America from $161.00 to $175.00 in a report issued on Thursday morning,Benzinga reports. The brokerage currently has a ...
Members of Congress have traded $JNJ stock 22 times in the past 6 months. Of those trades, 11 have been purchases and 11 have been sales. Here’s a breakdown of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results